Effective Date of Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses

Document ID: FDA-2012-N-0378-0001
Document Type: Proposed Rule
Agency: Food And Drug Administration
Topics: Medical Devices
Federal Register Number: 2012-16487
CFR Citation: 21 CFR Part 890
View Document:  View as format pdf View as format html

Details Information

Abstract: Classification due July 23, 2012
Document Subtype: Notice of Proposed Rulemaking (NPRM)
Received Date: July 06 2012, at 12:00 AM Eastern Daylight Time
Start-End Page: 39953 - 39959
Page Count: 7
Comment Start Date: July 6 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: October 4 2012, at 11:59 PM Eastern Standard Time

Attachments:

Index for References

View Attachment: View as format pdf

Ref 11 George In Vitro Mechanisms of Cell Proliferation Induction Induction A Novel Bioactive Treatment for Accelerating Wound Healing Wounds 14 p 107 115

View Attachment:

Ref 2 Jones Electromagnetic field interference and cardiac pacemakers Jones S L Electromagnetic Field Interference and Cardiac Pacemakers Physical Therapy 56 9 p 1013 1018 1976

View Attachment:

Ref 1 Inrich W J M de Bakker and H J Bisping Electromagnetic interference in implantable pacemakers in Implantable Pacemakers Pacing and Clinical Electrophysiology 1 1 p 52 61 1978

View Attachment:

Ref 10 Martin C J et al An Evaluation of Radiofrequency Exposure From Therapeutic Diathermy Equipment in the Light of Current Recommendations Clinical Physics and Physiological Measurement 11 1 p 53 63

View Attachment: View as format pdf

Ref 12 Elliott Bennett Guerrero et al Gentamicin Collagen Sponge for Infection Prophylaxis in Colorectal Surgery New England Journal of Medicine 363, no. 11 1038 1049 2010

View Attachment:

Ref 13 Kaplan Aaron V et al Medical Device Development: From Prototype to Regulatory Approval Circulation 109 no 25 3068 3072

View Attachment:

Ref 14 Lionberger FDA Critical Path Initiatives Opportunities for Generic Drug Development

View Attachment:

Ref 15 Makower Joshua FDA Impact on US Medical Technology Innovation A Survey of Over 200 Medical Technology Companies

View Attachment: View as format pdf

Ref 16 Geiger Dale R FY 2003 and FY 2004 Unit Costs for the Process of Medical Device Review

View Attachment: View as format pdf

Ref 17 U.S. Small Business Administration, "Table of Small Business Size Standards Matched to North American Industry

View Attachment: View as format pdf

Ref 3 Murray C C S Kitchen Effect of Pulse Repetition Rate on the Perception of Thermal Sensation With Pulsed Shortwave Diathermy Physiotherapy Research International 52 p 73 84 2000

View Attachment:

Ref 4 Erdman W J Peripheral Blood Flow Measurements During Application of Pulsed High Frequency Currents American Journal of Orthopedics 8 p 196 197 1960

View Attachment:

Ref 5 Ruggera P S et al In Vitro Assessment of Tissue Heating Near Metallic Medical Implants by Exposure to Pulsed Radio Frequency Diathermy Physics in Medicine and Biology 48 17 p 2919 2928 2003

View Attachment:

Ref 6 FDA Summary Minutes Meeting of the Circulatory System Devices Advisory Panel Center for Devices and Radiological Health Gaithersburg Holiday Inn, Gaithersburg MD available at

View Attachment: View as format pdf

Ref 7 FDA Patient Safety News, Show 13 Warning on Diathermy and Implanted Leads

View Attachment: View as format pdf

Ref 8 Kloth L et al Therapeutic Microwave and Shortwave Diathermy A Review of Thermal Effectiveness, Safe Use, and State of the Art HHS Publication FDA 85 8237 1984

View Attachment: View as format pdf

Ref 9 Shields N N O Hare and J Gormley An Evaluation of Safety Guidelines to Restrict Exposure to Stray Radiofrequency Radiation From Short Wave Diathermy Units Physics in Medicine and Biology 49 13 p 2999 3015 2004

View Attachment: View as format pdf

Comments

    View All
Total: 10
Albert Einstein College of Medicine - Comment
Posted: 10/05/2012     ID: FDA-2012-N-0378-0010

Oct 04,2012 11:59 PM ET
James Zucherman M.D. (St. Mary's Spine Center) - Comment
Posted: 10/05/2012     ID: FDA-2012-N-0378-0011

Oct 04,2012 11:59 PM ET
Jerel Glassman, MPH, DO (St Mary's Spine Center) Comment
Posted: 10/05/2012     ID: FDA-2012-N-0378-0012

Oct 04,2012 11:59 PM ET
Columbia University - Comment
Posted: 10/10/2012     ID: FDA-2012-N-0378-0013

Oct 04,2012 11:59 PM ET
Ivivi Health Sciences - Comment
Posted: 10/10/2012     ID: FDA-2012-N-0378-0015

Oct 04,2012 11:59 PM ET

Related Documents

   
Total: 4